Although the importance of AR in breast cancer has been challenged, there is sufficient evidence that its action in ERα-negative breast cancer may involve increase in cell proliferation and anti-apoptosis, steps that lead to poor outcomes from cancer treatment. The gene discussed is ESR1; the disease is breast carcinoma.